NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.078
-0.052 (-4.60%)
Sep 5, 2025, 5:29 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 120.08 million as of September 5, 2025. Its market cap has increased by 21.70% in one year.
Market Cap
120.08M
Enterprise Value
103.37M
Revenue
10.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.08
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 120.08M, an increase of 263.60%. That is a compound annual growth rate of 17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 120.08M | -42.15% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | 415.32M | 202.15% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.82B |
| Sectra AB | 63.08B |
| Getinge AB | 56.93B |
| Camurus AB | 43.05B |
| Medicover AB | 40.46B |
| Asker Healthcare Group AB | 36.45B |
| BioArctic AB | 27.87B |
| AddLife AB | 21.37B |